RIL
DERM icon

Rothschild Investment LLC’s Journey Medical DERM Stock Holding History

Rothschild Investment LLC’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177 Buy
+25
New +$143 ﹤0.01% 3452

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.9B AUM 23.65% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Rothschild Investment LLC's DERM Position: Q2 2026 in Review

Rothschild Investment LLC opened a new position in Journey Medical (DERM) in Q2 2026: 25 shares worth $177. The stake represents ﹤0.01% of the portfolio and ranks #3452 among its holdings.

14 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Rothschild Investment LLC held 25 shares of Journey Medical worth $177 as of Q2 2026.
  • Journey Medical was a new Rothschild Investment LLC position in Q2 2026.
  • Journey Medical made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3452 holding.
  • 14 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.